Stryker is one of the world's leading medical technology companies, offering innovative products and services that help improve patient and hospital outcomes. The COVID-19 pandemic has led to severe disruptions in the market and the global economy, affecting operations and financial performance. The company achieved reported net sales growth of 19.2% in 2021, with a focus on maintaining a long-term capital allocation strategy that prioritizes acquisitions, dividends, and share repurchases. In 2021, Stryker completed acquisitions, including Gauss Surgical, Inc., which developed an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery, highlighting the integration of digital technologies into their operations. The firm’s IT capabilities are essential in transforming its business processes and enhancing competitive advantage through effective resource allocation and management. The company’s financial condition remains strong, with substantial cash generation from operations, which supports its investment in technology and innovation. Stryker’s capital allocation strategy is designed to leverage its IT resources and capabilities to respond to changing market dynamics and consumer demands. The firm’s operational flexibility is enhanced through disciplined spending on research, development, and engineering, which increased in 2021 to facilitate growth and integrate recent acquisitions. The company’s focus on information management capability ensures the provision of accurate and timely data to support strategic decision-making and operational efficiency. Stryker’s ability to mobilize and deploy IT-based resources in conjunction with other strategic resources is critical in achieving organizational goals and enhancing firm performance. The company’s governance practices and strategic management are aligned with its objectives to optimize business processes and improve market responsiveness. The ongoing evaluation of its technology portfolio and infrastructure capability is vital for maintaining competitive positioning and driving innovation. Stryker’s commitment to enhancing its IT systems and capabilities is evident in its approach to managing external influences and ensuring compliance with regulatory contexts. The firm’s emphasis on digital transformation and the integration of big data analytics into its operations supports its objectives for performance improvement and operational effectiveness. As Stryker navigates the challenges posed by the pandemic and market restructuring, its strategic resource allocation and investment decisions will continue to focus on enhancing IT effectiveness and leveraging technology functionalities to create business value and drive performance outcomes.